Antipsychotics for aggressive behavior in patients with intellectual disability--an acceptable standard of care?

Affiliations

Comment

Elaine Tierney et al. Nat Clin Pract Neurol. 2008 Aug.

. 2008 Aug;4(8):418-9.

doi: 10.1038/ncpneuro0850. Epub 2008 Jun 24.

¹ Hopkins University School of Medicine, Kennedy Krieger Institute, Baltimore, MD 21211, USA. tierney@kennedykrieger.org

No abstract available

Comment on

Risperidone, haloperidol, and placebo in the treatment of aggressive challenging behaviour in patients with intellectual disability: a randomised controlled trial.
Tyrer P, Oliver-Africano PC, Ahmed Z, Bouras N, Cooray S, Deb S, Murphy D, Hare M, Meade M, Reece B, Kramo K, Bhaumik S, Harley D, Regan A, Thomas D, Rao B, North B, Eliahoo J, Karatela S, Soni A, Crawford M. Tyrer P, et al. Lancet. 2008 Jan 5;371(9606):57-63. doi: 10.1016/S0140-6736(08)60072-0. Lancet. 2008. PMID: 18177776 Clinical Trial.